Editor's Highlights-July 2025.

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by painful nodules, abscesses, and tunnels. This issue highlights key advances in understanding its pathogenesis and improving clinical care. New data suggest that the haptoglobin 2-2 genotype may be linked to familial HS and increased flare frequency, pointing toward potential applications in risk stratification. Another study explores the role of neutrophil extracellular traps (NETs) in HS, identifying their presence in both lesional and perilesional skin, and correlating serum NET markers with disease severity-findings that may inform future biomarker development. A comprehensive review addresses therapeutic strategies during pregnancy and lactation, evaluating the safety of topical, systemic, and biologic therapies to support individualized, safe treatment choices. Additionally, a complex surgical case illustrates the successful management of massive scrotal lymphedema in late-stage HS, emphasizing the value of integrated medical and surgical care. Together, these studies underscore the importance of personalized and multidisciplinary approaches in HS management.